Skip to main content
. 2022 Oct 8;101(12):102232. doi: 10.1016/j.psj.2022.102232

Table 2.

Muramidase activity (LSU (F)/kg) and recovery (%) from the feed in starter, grower, and finisher phases in Experiments 1 and 2.

Phase feeding, Exp. 1 MUR1 doses LSU (F)/kg
0 15,000 25,000 35,000
Starter (1–21 d)
MUR activity LSU(F)/kg 1,721 15,751 24,648 34,458
MUR recovery (%) 0 105 99 99
Grower (22–35 d)
MUR activity LSU(F)/kg 592 13,859 25,652 33,653
MUR recovery (%) 0 92 103 96
Finisher (36–43 d)
MUR activity LSU(F)/kg 454 11,556 21,900 31,027
MUR recovery (%) 0 77 88 89
Phase feeding, Exp. 2 MUR1 doses LSU (F)/kg
0 25,000 35,000
Starter (1–21 d)
MUR activity LSU(F)/kg 1,504 27,458 41,824
MUR recovery (%) 0 109 119
Grower (22–35 d)
MUR activity LSU(F)/kg 1,505 21,047 32,889
MUR recovery (%) 0 84 94
Finisher (36–42 d)
MUR activity LSU(F)/kg 1,585 20,013 29,752
MUR recovery (%) 0 80 85
1

Muramidase (gene coding Muramidase 007 obtained from the fungus Acremonium alcalophilum (strain 114.92), Novozymes A/S (Bagsvaerd, Denmark) were included according to the treatments (0, 15,000 LSU (F)/kg, 25,000 LSU (F)/kg and 35,000 LSU (F)/kg).